Amedeo Massacesi Selected Research

Macular Degeneration (Age-Related Maculopathy)

5/2019	Increased soluble urokinase plasminogen activator receptor (suPAR) levels in neovascular age-related macular degeneration: a role for inflammation in the pathogenesis of the disease?
6/2009	Retinal angiomatous proliferation: natural history and progression of visual loss.
11/2006	Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy.
12/2005	Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amedeo Massacesi Research Topics

Disease

4	Choroidal Neovascularization 02/2020 - 01/2012
4	Macular Degeneration (Age-Related Maculopathy) 05/2019 - 12/2005
2	Fibrosis (Cirrhosis) 02/2020 - 06/2009
1	Vision Disorders (Hemeralopia) 09/2022
1	Inflammation (Inflammations) 05/2019
1	Epiretinal Membrane (Epiretinal Membranes) 01/2016
1	Hemorrhage 01/2016
1	Atrophy 01/2016
1	Myopia 01/2012
1	Disease Progression 06/2009

Drug/Important Bio-Agent (IBA)

4	Retinaldehyde (Retinal)IBA 09/2022 - 12/2005
4	Fluorescein (Funduscein)FDA LinkGeneric 01/2016 - 11/2006
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2006 - 12/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020
1	Urokinase Plasminogen Activator ReceptorsIBA 05/2019
1	Biomarkers (Surrogate Marker)IBA 05/2019
1	Bevacizumab (Avastin)FDA Link 01/2012

Therapy/Procedure

1	Therapeutics 02/2020